3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Muscle Weakness

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Muscle Weakness in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Horstink, MW; Oyen, WJ; Veltman, J; Vogels, OJ	1

Other Studies

1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Muscle Weakness

Article	Year
Decreased striatal dopamine D2 receptor binding in amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA): D2 receptor down-regulation versus striatal cell degeneration. Journal of the neurological sciences, 2000, Nov-01, Volume: 180, Issue:1-2 Topics: Amyotrophic Lateral Sclerosis; Benzamides; Binding Sites; Dopamine Antagonists; Down-Regulation; Female; Humans; Hypokinesia; Iodine Radioisotopes; Male; Middle Aged; Multiple System Atrophy; Muscle Weakness; Neostriatum; Nerve Degeneration; Pyrrolidines; Radioligand Assay; Receptors, Dopamine D2	2000

Article

Year

Decreased striatal dopamine D2 receptor binding in amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA): D2 receptor down-regulation versus striatal cell degeneration.

Journal of the neurological sciences, 2000, Nov-01, Volume: 180, Issue:1-2

Topics: Amyotrophic Lateral Sclerosis; Benzamides; Binding Sites; Dopamine Antagonists; Down-Regulation; Female; Humans; Hypokinesia; Iodine Radioisotopes; Male; Middle Aged; Multiple System Atrophy; Muscle Weakness; Neostriatum; Nerve Degeneration; Pyrrolidines; Radioligand Assay; Receptors, Dopamine D2

2000